Obesity in adults: a clinical practice guideline
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Machine scores (provisional)
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
- Teacher spread
- 0.341 · how far apart the two teachers sit on this one work
- Validation status
score_only:v0-immature-baseline· verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it
Abstract
besity is a complex chronic disease in which abnormal or excess body fat (adiposity) impairs health, increases the risk of long-term medical complications and reduces lifespan. 1 Epidemiologic studies define obesity using the body mass index (BMI; weight/height 2 ), which can stratify obesity-related health risks at the population level. Obesity is operationally defined as a BMI exceeding 30 kg/m 2 and is subclassified into class 1 (30-34.9), class 2 (35-39.9) and class 3 ( 40). At the population level, health complications from excess body fat increase as BMI increases. At the individual level, complications occur because of excess adiposity, location and distribution of adiposity and many other factors, including environmental, genetic, biologic and socioeconomic factors (Box 1). ver the past 3 decades, the prevalence of obesity has steadily increased throughout the world, Importantly, severe obesity has increased more than fourfold and, in 2016, affected an estimated 1.9 million Canadian adults. besity has become a major public health issue that increases health care costs People with obesity experience pervasive weight bias and stigma, which contributes (independent of weight or BMI) to increased morbidity and mortality. 17 Obesity is caused by the complex interplay of multiple genetic, metabolic, behavioural and environmental factors, with the latter thought to be the proximate cause of the substantial GUIDELINE
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- Canadian Medical Association Journal
- Topic
- Pharmacology and Obesity Treatment
- Field
- Medicine
- Canadian institutions
- McMaster UniversitySheridan CollegeConcordia UniversityLibin Cardiovascular Institute of AlbertaKingston Health Sciences CentreHôpital du Sacré-Cœur de MontréalInstitut universitaire de cardiologie et de pneumologie de QuébecHamilton Medical Research GroupPopulation Health Research InstituteHumber River Regional HospitalBP (Canada)Simon Fraser UniversityCanadian Obesity NetworkQueen's UniversitySouth Health CampusUniversity of ReginaAlberta HealthHeart and Stroke FoundationIsland HealthYork UniversityUniversity of CalgaryProvidence Health CareUniversity Health NetworkUniversity of AlbertaDalhousie UniversityUniversity of OttawaRegina General HospitalLMC Diabetes & Endocrinology (Canada)Memorial University of NewfoundlandUniversity of TorontoImpactFoothills Medical CentreUniversité de SherbrookeCentre for Addiction and Mental HealthOttawa HospitalSt. Michael's HospitalCentre Hospitalier Universitaire de SherbrookeUniversity of British Columbia
- Funders
- Obesity CanadaEuropean Foundation for the Study of DiabetesAlmond Board of CaliforniaInternational Nut and Dried Fruit CouncilBausch HealthNovo NordiskInternational Sweeteners AssociationUniversity of TorontoGlycemic Index FoundationSociety for EndocrinologyCanadian Institutes of Health ResearchPepsiCoEuropean Food Safety AuthorityCanadian Cardiovascular SocietyDiabetes CanadaHealth CanadaValeant Pharmaceuticals InternationalNestlé Health ScienceSunovionSoy Nutrition InstituteDairy Farmers of CanadaPhysicians Committee for Responsible MedicineLoblaw Companies LimitedEli Lilly and CompanyAstraZeneca
- Keywords
- ObesityBody mass indexGuidelineMedicineBody volume indexDiseaseClinical PracticeInternal medicineGerontologyClassification of obesityFat massPhysical therapyPathology
- Has abstract in OpenAlex
- yes